Page last updated: 2024-11-06

bpde-ii

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

BPDE-II: structure given in first source; a DNA adduct [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID44468
MeSH IDM0195529

Synonyms (24)

Synonym
benzo(a)pyrene, 7-beta,8-alpha-dihydroxy-9-beta,10-beta-epoxy-7,8,9,10-tetrahydro-, (-)-cis
benzo(a)pyrene, 7,8,9,10-tetrahydro-7-alpha,8-beta-dihydroxy-9-alpha,10-alpha-epoxy-, (-)-z-
brn 4356683
(-)-bp-7-beta,8-alpha-diol-9-beta,10-beta-epoxide 1
(-)-cis-7-beta,8-alpha-dihydroxy-9-beta,10-beta-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene
syn-(-)-benzo(a)pyrene-7,8-diol-9,10-oxide
bpde-ii
(-)-syn-benzo(a)pyrene-7,8-dihydrodiol-9,10-epoxide
ccris 794
63357-09-5
6b9y97b2j0 ,
unii-6b9y97b2j0
58917-91-2
benzo(a)pyrene-7,8-dihydrodiol 9,10-epoxide, syn-(-)-
(7r,8s,9r,10s)-(-)-syn-benzo(a)pyrene-7,8-diol 9,10-epoxide
benzo(10,11)chryseno(3,4-b)oxirene-7,8-diol, 7,8,8a,9a-tetrahydro-, (7r-(7.alpha.,8.beta.,8a.beta.,9a.beta.))-
syn-benzo(a)pyrene-7,8-diol-9,10-epoxide, (-)-trans-
syn-bpde, (-)-
benzo(10,11)chryseno(3,4-b)oxirene-7,8-diol, 7,8,8a,9a-tetrahydro-, (7r,8s,8ar,9as)-
(7r,8s,9r,10s)-7,8-dihydroxy-9,10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene
(-)-syn-benzo[a]pyrene-7,8-dihydrodiol-9,10-epoxide
rel-(7r,8s,8ar,9as)-7,8,8a,9a-tetrahydrobenzo[1,12]tetrapheno[10,11-b]oxirene-7,8-diol
(3s,5r,6s,7r)-4-oxahexacyclo[11.6.2.02,8.03,5.010,20.017,21]henicosa-1(20),2(8),9,11,13(21),14,16,18-octaene-6,7-diol
DTXSID301033184
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's3 (50.00)18.2507
2000's2 (33.33)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]